Ironwood pharmaceuticals boston
WebPrior to Cyclerion, Todd was a co-founder of Ironwood Pharmaceuticals where he held a number of scientific program and functional leadership roles, including leading sGC stimulator discovery and early development efforts at Ironwood. ... From 2007 to 2011, she served as senior vice president of administration and general counsel for Boston ... WebFeb 26, 2024 · BOSTON--(BUSINESS WIRE)--Feb 26, 2024-- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a GI-focused healthcare company, today announced that …
Ironwood pharmaceuticals boston
Did you know?
WebJun 16, 2024 · Founded in 1998, Ironwood Pharmaceuticals is headquartered in Boston, Massachusetts. We routinely post information that may be important to investors on our website at www.ironwoodpharma.com . WebApr 11, 2024 · Ironwood Pharmaceuticals Inc. on Tuesday said it has eliminated the role of chief operating officer in a streamlining of the healthcare company's executive leadership team. As a result, the Boston ...
WebFeb 27, 2024 · The corporate mailing address for Mr. Currie and other Ironwood Pharmaceuticals executives is 100 SUMMER STREET SUITE 2300, BOSTON MA, 02110. Ironwood Pharmaceuticals can also be reached via phone at (617) 621-7722 and via email at [email protected]. Has Mark G. Currie been buying or selling shares of … WebApr 14, 2024 · Ironwood Pharmaceuticals, Inc is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics segment. The company was founded on January 5, 1998 and is headquartered in Boston, MA.
WebMay 6, 2024 · BOSTON-- (BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, announced today that its Board of Directors has authorized a new share repurchase program under which the Company may repurchase up to $150 million of its outstanding shares of common stock through December 2024. WebNov 4, 2024 · IND for CNP-104 Accepted by FDA; Clinical Trials Planned for the End of 2024 Ironwood to Make a Payment of approximately $20 Million in Upfront and Near-Term …
Web1 day ago · BOSTON-- (BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today reported its third quarter 2024 results and recent business performance. 5 months ago - Business Wire Ironwood Pharmaceuticals to Host Third Quarter 2024 Investor Update Call
WebMar 6, 2024 · Ironwood Pharmaceuticals is part of the Manufacturing industry, and located in Massachusetts, United States. Ironwood Pharmaceuticals Location 100 Summer St Ste 2300, Boston, Massachusetts, 02110, United States Description Industry Pharmaceuticals Healthcare Discover more about Ironwood Pharmaceuticals Org Chart - Ironwood … china tactile membrane keyboardWebMar 5, 2024 · Ironwood Pharmaceuticals, headquartered in Boston, Massachusetts, and established in 1998, is a specialty and generic drug manufacturing company specializing … grammy song of the year 1979WebIronwood Pharmaceuticals. Ironwood is dedicated to advancing the treatment of GI diseases and redefining the standard of care for millions of GI patients. Industry … china tactical dry bagWebMay 17, 2024 · Ironwood Pharmaceuticals (Nasdaq:IRWD) is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients. china tactical backpack stockWebApr 15, 2024 · Ironwood Pharmaceuticals Company Profile . Ironwood Pharmaceuticals, Inc is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics segment. The company was founded on January 5, 1998 and is headquartered in Boston, MA. … grammy song of the year 1980WebFeb 17, 2024 · Founded in 1998, Ironwood Pharmaceuticals is headquartered in Boston, Massachusetts. We routinely post information that may be important to investors on our website at www.ironwoodpharma.com. In addition, follow us on Twitter and on LinkedIn . About LINZESS (linaclotide) china tailor made toursWebFeb 13, 2024 · BOSTON-- ( BUSINESS WIRE )-- Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the supplemental New Drug Application (sNDA) for LINZESS ® (linaclotide) for the treatment of children and adolescents ages 6 … china tainted milk scandal